Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (22)

1

The Intelence aNd pRezista Once A Day Study (INROADS) : a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects

enthalten in: HIV medicine | 2015

von Ruane, P. | Brinson, C. | Ramgopal, M. | +29

2

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1 : results of a study of darunavir/ritonavir 600/100 mg administered twice daily

enthalten in: HIV medicine | 2014

von Zorrilla, C. | Wright, R. | Osiyemi, O. | +8

ErratumIn: HIV Med. 2019 Aug;20(7):496-499. - PMID 31318137

3

Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers : a two-panel, two-way, two-period, randomized trial

enthalten in: HIV medicine | 2013

von Kakuda, T. | DeMasi, R. | van Delft, Y. | +1

4

Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy

enthalten in: HIV medicine | 2011

von Lambert, J. | Else, L. | Jackson, V. | +10

5

Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study

enthalten in: HIV medicine | 2007

von Mallolas, J. | Blanco, J. | Labarga, P. | +17

6

Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free Hospital

enthalten in: HIV medicine | 2007

von Smith, C. | Phillips, A. | Youle, M. | +5

7

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors : 96-week outcomes of HIV-NAT 009

enthalten in: HIV medicine | 2005

von Boyd, M. | Siangphoe, U. | Ruxrungtham, K. | +5

8

The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations

enthalten in: HIV medicine | 2005

von Shafran, S. | Mashinter, L. | Roberts, S.

9

The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy

enthalten in: HIV medicine | 2005

von Cardiello, P. | Srasuebkul, P. | Hassink, E. | +6

10

Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients : comparison of 800/100 mg and 400/100 mg twice daily

enthalten in: HIV medicine | 2005

von Konopnicki, D. | De Wit, S. | Poll, B. | +3